{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:22:12Z","timestamp":1787671332469,"version":"build-2736575974"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Am Acad Orthop Surg","JAAOS"],"published-print":{"date-parts":[[2026,1,15]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Tranexamic acid (TXA) is frequently used in knee and hip arthroplasty because of its benefits. The literature is scarce on TXA and total ankle arthroplasty (TAA). The current systematic review aims to present the available literature on the subject.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Two independent authors performed a systematic literature search using the following databases: PubMed, Embase, and the Cochrane Library. The Preferred Reporting Items for Systematic Reviews and Meta-Analysis protocol and the Cochrane Handbook guidelines were followed. The search criteria were based on TAA and TXA. The MINORS score criteria were used to evaluate the strength and quality of the selected studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of eight studies including 263 TAA were completed with the usage of TXA and 228 TAA were without TXA. The average blood loss and change in hemoglobin in the TXA group was 335.4 mL and 1.45 g\/dL, respectively. In the non-TXA group, average blood loss and change in hemoglobin was 441.8 mL and 1.78 g\/dL, respectively. The total number of complications and wound complications reported in all studies for the TXA group were 19% and 6.8%; in the non-TXA group, 33.3% and 16.7% were observed, respectively. The difference in wound complication rate was statistically significant (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.014). Trends favoring the TXA group were found for lower transfusion, pulmonary embolism, deep vein thrombosis, and cerebrovascular accident.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The utilization of TXA in TAA appears to be safe and effective. Wound complication rate was the only finding with a notable difference favoring the TXA group. The rest of the data from this systematic review demonstrate a trend toward lower in blood loss, hemoglobin decrease, and total complications when using TXA in TAA. Larger prospective studies and randomized controlled trials are needed to further guide evidence-based guidelines.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5435\/jaaos-d-25-00365","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T21:00:24Z","timestamp":1753736424000},"page":"e284-e292","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The Safety Profile and Outcomes of Tranexamic Acid for Total Ankle Arthroplasty: A Systematic Review"],"prefix":"10.5435","volume":"34","author":[{"given":"Rodrigo","family":"Encinas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Hall","family":"Kiriluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Hardman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Benjamin","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,24]]},"reference":[{"key":"R1-20260511","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/15563316231208716","article-title":"The efficacy and safety of tranexamic acid in total hip and knee arthroplasty: A literature review","volume":"20","author":"Borsinger","year":"2024","journal-title":"HSS J"},{"key":"R2-20260511","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1016\/j.arth.2024.04.033","article-title":"Association between tranexamic acid and decreased periprosthetic joint infection risk in patients undergoing total hip and knee arthroplasty: A systematic review and meta-analysis of over 2 million patients","volume":"39","author":"Elmenawi","year":"2024","journal-title":"J Arthroplasty"},{"key":"R3-20260511","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.arth.2022.08.026","article-title":"Tranexamic acid and prothrombotic complications following total hip and total knee arthroplasty: A population-wide safety analysis accounting for surgeon selection bias","volume":"38","author":"Heckmann","year":"2023","journal-title":"J Arthroplasty"},{"key":"R4-20260511","doi-asserted-by":"crossref","first-page":"732","DOI":"10.5435\/JAAOS-D-14-00223","article-title":"Tranexamic acid in hip and knee arthroplasty","volume":"23","author":"Melvin","year":"2015","journal-title":"J Am Acad Orthop Surg"},{"key":"R5-20260511","doi-asserted-by":"crossref","first-page":"6961540","DOI":"10.1155\/2021\/6961540","article-title":"Complications of tranexamic acid in orthopedic lower limb surgery: A meta-analysis of randomized controlled trials","volume":"2021","author":"Reale","year":"2021","journal-title":"Biomed Res Int"},{"key":"R6-20260511","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.2106\/JBJS.17.00908","article-title":"Intravenous versus topical tranexamic acid in total knee arthroplasty: Both effective in a randomized clinical trial of 640 patients","volume":"100","author":"Abdel","year":"2018","journal-title":"J Bone Joint Surg Am"},{"key":"R7-20260511","first-page":"e75741","article-title":"Use of oral and intravenous tranexamic acid in total knee arthroplasty and total hip arthroplasty procedures","volume":"16","author":"Manes","year":"2024","journal-title":"Cureus"},{"key":"R8-20260511","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.bja.2022.11.003","article-title":"Effectiveness of oral versus intravenous tranexamic acid in primary total hip and knee arthroplasty: A randomised, non-inferiority trial [published correction appears in Br J Anaesth. 2023;131:190. doi: 10.1016\/j.bja.2023.04.032.]","volume":"130","author":"DeFrancesco","year":"2023","journal-title":"Br J Anaesth"},{"key":"R9-20260511","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00402-023-05126-z","article-title":"The efficacy and safety of tranexamic acid utilization in total ankle arthroplasty: A systematic review and meta-analysis","volume":"144","author":"Edelstein","year":"2024","journal-title":"Arch Orthop Trauma Surg"},{"key":"R10-20260511","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jisako.2024.03.009","article-title":"Tranexamic acid reduces perioperative blood loss and postoperative hemoglobin loss during total ankle arthroplasty: A systematic review and meta-analysis of clinical comparative studies","volume":"9","author":"Butler","year":"2024","journal-title":"J ISAKOS"},{"key":"R11-20260511","first-page":"19386400231191694","article-title":"How to prevent wound complications after total ankle arthroplasty through anterior approach: A systematic review on current treatment options","author":"Artioli","year":"2023","journal-title":"Foot Ankle Specialist"},{"key":"R12-20260511","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1177\/10711007221114139","article-title":"Tranexamic acid utilization in foot and ankle surgery: A meta-analysis","volume":"43","author":"Salameh","year":"2022","journal-title":"Foot Ankle Int"},{"key":"R13-20260511","doi-asserted-by":"crossref","first-page":"302","DOI":"10.17161\/kjm.vol16.21262","article-title":"Tranexamic acid in foot and ankle surgery: A systematic review and meta-analysis","volume":"16","author":"Dombrowski","year":"2023","journal-title":"Kans J Med"},{"key":"R14-20260511","doi-asserted-by":"crossref","first-page":"2473011420975419","DOI":"10.1177\/2473011420975419","article-title":"Tranexamic acid use in foot and ankle surgery","volume":"5","author":"Johns","year":"2020","journal-title":"Foot Ankle Orthop"},{"key":"R15-20260511","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"R17-20260511","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R18-20260511","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","article-title":"Methodological index for non-randomized studies (minors): Development and validation of a new instrument","volume":"73","author":"Slim","year":"2003","journal-title":"ANZ J Surg"},{"key":"R19-20260511","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/hae.14909","article-title":"A single-centre experience of 29 total ankle replacement in haemophiliac patients: Therapeutic management, factor consumption and cost","volume":"30","author":"Favrelle","year":"2024","journal-title":"Haemophilia"},{"key":"R20-20260511","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/19386400231207276","article-title":"Safety and efficacy of tranexamic acid in total ankle arthroplasty","volume":"18","author":"Ghobrial","year":"2025","journal-title":"Foot Ankle Spec"},{"key":"R21-20260511","doi-asserted-by":"crossref","first-page":"789","DOI":"10.5435\/JAAOS-D-21-01064","article-title":"Tranexamic acid associated with less wound complications in ankle and hindfoot surgery: Level III, retrospective cohort study","volume":"30","author":"Moore","year":"2022","journal-title":"J Am Acad Orthop Surg"},{"key":"R22-20260511","article-title":"Tranexamic acid reduces perioperative blood loss and hemarthrosis in total ankle arthroplasty","volume":"47","author":"Nodzo","year":"2018","journal-title":"Am J Orthop (Belle Mead NJ)"},{"key":"R23-20260511","doi-asserted-by":"crossref","first-page":"9542","DOI":"10.1038\/s41598-022-13861-3","article-title":"The efficacy and safety of intravenous tranexamic acid on blood loss during total ankle replacement: A retrospective study","volume":"12","author":"Tan","year":"2022","journal-title":"Sci Rep"},{"key":"R24-20260511","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1007\/s00264-021-05140-z","article-title":"Outpatient total ankle replacement","volume":"45","author":"Sadoun","year":"2021","journal-title":"Int Orthop"},{"key":"R25-20260511","first-page":"e26706","article-title":"The effect of tranexamic acid on the outcome of total ankle replacement","volume":"14","author":"Ali","year":"2022","journal-title":"Cureus"},{"key":"R26-20260511","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1177\/1071100720934889","article-title":"Effect of tranexamic acid on wound complications and blood loss in total ankle arthroplasty","volume":"41","author":"Steinmetz","year":"2020","journal-title":"Foot Ankle Int"},{"key":"R27-20260511","doi-asserted-by":"crossref","first-page":"100433","DOI":"10.1016\/j.fastrc.2024.100433","article-title":"Total ankle arthroplasty incision management: What matters? A systematic review","volume":"4","author":"Sakkab","year":"2024","journal-title":"Foot Ankle Surg Tech Rep Cases"},{"key":"R28-20260511","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1177\/1071100716683341","article-title":"Operative wound complications following total ankle arthroplasty","volume":"38","author":"Gross","year":"2017","journal-title":"Foot Ankle Int"},{"key":"R29-20260511","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3113\/FAI.2010.0301","article-title":"Wound breakdown after total ankle arthroplasty","volume":"31","author":"Whalen","year":"2010","journal-title":"Foot Ankle Int"},{"key":"R30-20260511","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/1071100717735288","article-title":"Single-surgeon experience and complications of a fixed-bearing total ankle arthroplasty","volume":"39","author":"Pangrazzi","year":"2018","journal-title":"Foot Ankle Int"},{"key":"R31-20260511","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1177\/1071100714568869","article-title":"Infected total ankle arthroplasty: Risk factors and treatment options","volume":"36","author":"Patton","year":"2015","journal-title":"Foot Ankle Int"},{"key":"R32-20260511","doi-asserted-by":"crossref","first-page":"111008","DOI":"10.1016\/j.injury.2023.111008","article-title":"Does tranexamic acid increase venous thromboembolism risk among trauma patients? A prospective multicenter analysis across 17 level I trauma centers","volume":"54","author":"Knowlton","year":"2023","journal-title":"Injury"},{"key":"R33-20260511","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2106\/JBJS.23.00254","article-title":"Tranexamic acid is safe in patients with a history of venous thromboembolism undergoing total joint arthroplasty","volume":"106","author":"Richardson","year":"2024","journal-title":"J Bone Joint Surg Am"},{"key":"R34-20260511","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/1938640020983639","article-title":"Tranexamic acid in foot and ankle surgery: A topical review and value analysis","volume":"15","author":"Johns","year":"2022","journal-title":"Foot Ankle Spec"}],"container-title":["Journal of the American Academy of Orthopaedic Surgeons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-25-00365","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:42:27Z","timestamp":1787668947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-25-00365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5435\/jaaos-d-25-00365","relation":{},"ISSN":["1067-151X","1940-5480"],"issn-type":[{"value":"1067-151X","type":"print"},{"value":"1940-5480","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,24]]},"assertion":[{"value":"2025-03-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}